Extremities

Stryker Launches New Prophecy Infinity Resect-Through Guides

Building on Prophecy’s Legacy of Success, New System Offers Surgeons Fewer Steps, More Efficiency

November 16, 2021

MAHWAH, N.J.–(BUSINESS WIRE)–Stryker today launched the Prophecy® Infinity® Resect-Through Guides for use in total ankle replacement surgeries. The system represents the latest refinement of Stryker’s current industry gold standard technique, allowing surgeons to improve OR efficiency by reducing potentially time-consuming interoperative steps in a streamlined surgical process.

“The new Prophecy Infinity Resect-Through Guides System builds on the product line’s legacy of success in the foot and ankle market,” said Michael Rankin, VP Marketing and Medical Education, Stryker’s Foot & Ankle business. “After 35,000 cases planned over the last nine years, the latest offering in the Prophecy System continues to push innovation that will advance ease-of-use and accuracy in the operating room.”

The Prophecy Infinity Resect-Through Guides allow surgeons to take fewer steps in total ankle replacement surgeries than the Prophecy standard pin-through technique. The system helps increase efficiency in the OR by using just one guide for both drilling and cutting, reducing the number of steps in a patient’s surgical plan. Metal guides maintain cutting stability, while optional holes can couple alignment for the talus. The system also uses improved fluoroscopic visualization that can help surgeons view coronal alignment, positioning and implant size, all in one fluoro shot.

“The Prophecy Infinity Resect-Through Guides can save steps in the OR and allow for a firmer attachment of the Prophecy guides to the bone,” said Scott Ellis, MD, Foot and Ankle Surgeon and Associate Attending at Hospital for Special Surgery in New York. “With Stryker’s Resect-Through Guides, surgeons can enter the OR feeling confident that they are more likely to successfully follow their preoperative total ankle plan and achieve a well-aligned implant.”

More information about the Prophecy Infinity Resect-Through Guides is available at footankle.stryker.com.

About Stryker

Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical and Neurotechnology and Spine that help improve patient and hospital outcomes. More information is available at www.stryker.com.

Follow Stryker Foot & Ankle on LinkedIn and Stryker’s Trauma & Extremities division on Twitter.

A surgeon must always rely on his or her own professional clinical judgment when deciding whether to use a particular product when treating a particular patient. Stryker does not dispense medical advice and recommends that surgeons be trained in the use of any particular product before using it in surgery.

The information presented is intended to demonstrate the breadth of Stryker’s product offerings. A surgeon must always refer to the package insert, product label and/or instructions for use before using any of Stryker’s products. Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. Please contact your sales representative if you have questions about the availability of products in your area.

Contacts

Andrea Sampson, Sampson Public Relations Group
asampson@sampsonprgroup.com
562.304.0301

Print Friendly, PDF & Email

Chris J. Stewart

Chris currently serves as President and CEO of Surgio Health. Chris has close to 20 years of healthcare management experience, with an infinity to improve healthcare delivery through the development and implementation of innovative solutions that result in improved efficiencies, reduction of unnecessary financial & clinical variation, and help achieve better patient outcomes. Previously, Chris was assistant vice president and business unit leader for HPG/HCA. He has presented at numerous healthcare forums on topics that include disruptive innovation, physician engagement, shifting reimbursement models, cost per clinical episode and the future of supply chain delivery.

Related Articles

Back to top button